Mediolanum International Funds Limited (MIFL or the Company)
Date: November 2021
This is a summary of rights afforded to you as an investor whose name appears on the share/unit register of any of the Funds managed by Mediolanum International Funds Limited. This list is a summary and is non-exhaustive. Investors may also be afforded rights under other legislation or regulatory frameworks which are not addressed below. Should you require any further information relating to the terms of your investment and your rights, please refer to the prospectus and the constitutive document of the relevant Fund which can be accessed on our website. (Mediolanum (mifl.ie)) The Directory contained in the prosecutes of each relevant Fund contains information on the key providers to that Fund.
Investors in all jurisdictions within the European Union in which the Funds are offered can publicly avail of Information about the Funds on the MIFL website (Mediolanum (mifl.ie).This information includes the prospectus, key investor information documents (KIIDs), annual and semi-annual reports, the constitutional documents of the relevant Fund. (Mediolanum (mifl.ie)) These documents contain additional information on the various rights afforded to shareholders listed on the share register of the relevant Fund.
Redemption of Shares and dividend distributions
Investors are entitled to redeem their shareholding in the Fund (or any part thereof) and receive the redemption proceeds relating to such a redemption within the timeframe and subject to such conditions as detailed in the prospectus and the constitutive documents of the relevant Fund(s). Investors may be entitled to receive dividend distributions, depending on the share/unit class of the relevant Fund that they have a holding subject to such conditions as detailed in the prospectus and other constitution documents of the relevant Fund.
Voting rights and related matters
Investors have the right to vote (whether in ordinary or extraordinary general meeting or, where so permitted under the constitutive documents of the relevant collective investment scheme by way of a written resolution) on resolutions relating to the relevant Fund, sub-fund or share/unit class thereof in accordance with the conditions set down in the prospectus and constitutive documents of the relevant Fund. MIFL is required to provide each Investor with written notice of any such meeting in accordance with the procedures and timeframes outlined in the Fund’s constitutional document.
Investor complaints may be addressed to MIFL, the Trustee/Depositary, the Transfer Agent and Registrar, the Paying Agents and the Distributors as well as the Facility Agent (where relevant). They will be dealt with appropriately and as quickly as possible. Further information on the complaints procedure can be obtained free of charge from MIFL.
Right to take an action
Investors in a Fund may have the right to take action against MIFL in certain circumstances as outlined in the constitution documents of the relevant Fund e.g. material breach of contract. Also, investors have a regulatory right of action to pursue the relevant Depositary / Trustee of the Fund in respect of (i) any loss of an asset held in the custody of the Depositary or any delegate of the Depositary; or (ii) any other losses caused by the Depositary’s negligent or intentional failure to properly fulfil its obligations under applicable regulations, provided this does not lead to a duplication of redress or to unequal treatment of share/unit holders in the Fund.
Representative actions under Irish and Luxembourg Law
Currently under Irish and Luxembourg law1 , there is no formal representative action procedure in place which facilitates collective redress by consumers in respect of infringements of EU or national law. A collective redress mechanism, as required under Directive (EU) 2020/1828, must be implemented in EU member states by 25 June 2023.
Terminate marketing agreements within EU Member States
Please note, a decision may be taken at any time to terminate the arrangements made for the marketing of the Fund in any EEA Member State in which it is currently marketed. In such circumstances, Shareholders in the affected EEA Member State will be notified of this decision and will be provided with the opportunity to redeem their shareholding in the Fund free of any charges or deductions for at least 30 working days from the date of such notification.